[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2004026840A - Viable bacterium composition - Google Patents

Viable bacterium composition Download PDF

Info

Publication number
JP2004026840A
JP2004026840A JP2003284828A JP2003284828A JP2004026840A JP 2004026840 A JP2004026840 A JP 2004026840A JP 2003284828 A JP2003284828 A JP 2003284828A JP 2003284828 A JP2003284828 A JP 2003284828A JP 2004026840 A JP2004026840 A JP 2004026840A
Authority
JP
Japan
Prior art keywords
vitamin
bifidobacteria
present
growth
bacillus bifidus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003284828A
Other languages
Japanese (ja)
Other versions
JP4694777B2 (en
Inventor
Takaharu Mori
森 隆治
Katsuhiro Izumisawa
泉澤 勝弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Nitto Pharmaceutical Industries Ltd
Original Assignee
Eisai Co Ltd
Nitto Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd, Nitto Pharmaceutical Industries Ltd filed Critical Eisai Co Ltd
Priority to JP2003284828A priority Critical patent/JP4694777B2/en
Publication of JP2004026840A publication Critical patent/JP2004026840A/en
Application granted granted Critical
Publication of JP4694777B2 publication Critical patent/JP4694777B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for orally administering Bacillus bifidus and then proliferating the Bacillus bifidus in the intestines. <P>SOLUTION: The method for promoting the proliferation of the Bacillus bifidus by formulating vitamin B2, vitamin B6 and vitamin C together with the Bacillus bifidus is provided, a proliferation promotor for the Bacillus bifidus containing the vitamin B2, the vitamin B6 and the vitamin C is provided and a composition and a chewable preparation each containing the vitamin B2, the vitamin B6 and the vitamin C in addition to the Bacillus bifidus are provided. <P>COPYRIGHT: (C)2004,JPO

Description

 本発明はビフィズス菌を含有する組成物及びチュアブル剤、並びにビフィズス菌の増殖促進方法及び増殖促進剤に関する。 The present invention relates to a composition and chewable agent containing bifidobacteria, a method for promoting the growth of bifidobacteria, and a growth promoter.

 ビフィズス菌、乳酸菌は腸内細菌叢のいわゆる善玉菌であり、便秘、腹部膨満感の改善等の整腸作用を有するため医薬品又は食品として飲料や錠剤等の形態として広く服用されている。乳酸菌等を含有した組成物としては、特許文献1に、凍結乾燥された納豆菌、乳酸菌、酵母、ビタミン類及び糖分が混和され固形化された食品が開示され、また、特許文献2には、乳酸菌、糖化菌及び酪酸菌を有効成分とする3種菌共生混合物が開示されている。更に、特許文献3には、納豆菌、乳酸菌、オリゴ糖、玄米からなる抗酸化性組成物が開示されている。
特開昭59−59177号公報 特開昭63−63620号公報 特開平9−154535号公報
Bifidobacteria and lactic acid bacteria are so-called good bacteria of the intestinal bacterial flora, and have a bowel regulating action such as improvement of constipation and abdominal bloating, so they are widely used as pharmaceuticals or foods in the form of beverages or tablets. As a composition containing lactic acid bacteria and the like, Patent Document 1 discloses a freeze-dried natto fungus, lactic acid bacteria, yeast, vitamins, and a food in which sugars are mixed and solidified, and Patent Document 2 includes A symbiotic commensal mixture containing lactic acid bacteria, saccharifying bacteria and butyric acid bacteria as active ingredients is disclosed. Furthermore, Patent Document 3 discloses an antioxidant composition comprising natto bacteria, lactic acid bacteria, oligosaccharides, and brown rice.
JP 59-59177 JP-A 63-63620 Japanese Patent Laid-Open No. 9-154535

 ビフィズス菌は経口的に服用しても腸内に定着しにくいといわれており、服用後腸内において増殖させることが課題となっている。また、飲料としての形態は持ち運びに難点があり、錠剤は服用時に水を必要とするという欠点があり、剤形の点からも更に改善の余地があった。また前述の文献には、腸内浄化作用、整腸作用、抗酸化作用、抗潰瘍作用等を有することが示されているが、ビフィズス菌を腸内において増殖させる手段は開示されていない。本発明者は、これら課題を解決すべく鋭意検討し、以下に示す手段により課題を解決できることを見出し本発明を完成した。 Bifidobacteria are said to be difficult to settle in the intestine even if taken orally, and growing in the intestine after taking is a problem. Moreover, the form as a drink has a difficulty in carrying, the tablet has the fault of requiring water at the time of taking, and there was room for improvement from the point of a dosage form. In addition, the above-mentioned documents show that they have intestinal purification action, intestinal regulation action, antioxidant action, anti-ulcer action, etc., but do not disclose means for growing bifidobacteria in the intestine. The inventor has intensively studied to solve these problems, and found that the problems can be solved by the means described below, thereby completing the present invention.

 本発明は、ビフィズス菌に、ビタミンB2、ビタミンB6及びビタミンCを配合することによるビフィズス菌の増殖促進方法、ビタミンB2、ビタミンB6及びビタミンCを含有する、ビフィズス菌の増殖促進剤、並びにビフィズス菌、ビタミンB2、ビタミンB6及びビタミンCを含有する組成物又はチュアブル剤である。 The present invention relates to a method for promoting the growth of bifidobacteria by adding vitamin B2, vitamin B6 and vitamin C to bifidobacteria, a bifidobacteria growth promoter containing vitamin B2, vitamin B6 and vitamin C, and bifidobacteria , Vitamin B2, Vitamin B6, and Vitamin C.

 本発明の増殖促進方法及び増殖促進剤により、ビフィズス菌を腸内において有効に増殖させることができる。 Bifidobacteria can be effectively propagated in the intestine by the growth promoting method and growth promoting agent of the present invention.

 本発明におけるビフィズス菌とは、ビフィドバクテリウム属に属する菌を意味し、例えばビフィダム菌、ブレーベ菌、ロンガム菌又はアンドレッセンティス菌等を挙げることができ、特にBifidobacterium longum NTが好ましい。 The bifidobacteria in the present invention means a bacterium belonging to the genus Bifidobacterium, and examples thereof include bifidum bacterium, breve bacterium, longum bacterium, and andrescentis bacterium, and Bifidobacterium longum NT is particularly preferable.

 本発明におけるビフィズス菌の含有量は、それぞれ一回に服用される菌数では通常105〜109cfuであり、好ましくは106〜109cfuである。重量に換算すると、一回の服用当たり10〜200mg、好ましくは20〜150mgである。 The content of bifidobacteria in the present invention is usually 10 5 to 10 9 cfu, preferably 10 6 to 10 9 cfu in terms of the number of bacteria taken at one time. In terms of weight, it is 10 to 200 mg, preferably 20 to 150 mg per dose.

 本発明においては、ビフィズス菌に、ビタミンB2、ビタミンB6及びビタミンCを添加することにより、ビフィズス菌を増殖促進することができる。ビタミンB2はリボフラビンとも呼ばれ、リン酸リボフラビン、補酵素型リボフラビン等の種類があるが、特に遊離体が好ましい。ビタミンB6は、ピリドキシンとも呼ばれ、ビタミンCは、アスコルビン酸とも呼ばれる。本発明においては、ビタミンB2は一回の服用当たり5〜30mg、好ましくは10〜20mgであり、ビタミンB6は一回の服用当たり10〜100mg、好ましくは15〜50mgであり、ビタミンCは一回の服用当たり100〜1000mg、好ましくは200〜500mgである。 In the present invention, the growth of bifidobacteria can be promoted by adding vitamin B2, vitamin B6 and vitamin C to the bifidobacteria. Vitamin B2 is also called riboflavin and includes riboflavin phosphate, coenzyme type riboflavin, etc., but the free form is particularly preferable. Vitamin B6 is also called pyridoxine, and vitamin C is also called ascorbic acid. In the present invention, vitamin B2 is 5 to 30 mg, preferably 10 to 20 mg per dose, vitamin B6 is 10 to 100 mg, preferably 15 to 50 mg per dose, and vitamin C is used once. Per dose of 100 to 1000 mg, preferably 200 to 500 mg.

 本発明では、ビフィズス菌と、ビタミンB2、ビタミンB6及びビタミンCを含有する組成物又はチュアブル剤を服用すると、消化管内においてビフィズス菌の増殖が促進され、排便促進作用、整腸作用がもたらされるが、これらの作用が本願発明の目的である。 In the present invention, when a composition or chewable agent containing bifidobacteria and vitamin B2, vitamin B6, and vitamin C is taken, the growth of bifidobacteria is promoted in the digestive tract, resulting in a defecation promoting action and an intestinal regulating action. These actions are the object of the present invention.

 本発明にかかる組成物は、例えば通常の錠剤とするためには、乳糖、デンプン、結晶セルロース等の賦形剤、ヒドロキシプロピルセルロース等の結合剤を混合して溶媒を用いて造粒、乾燥後、ステアリン酸等の滑沢剤を添加して打錠し通常の錠剤を製造することができる。 For example, in order to obtain a normal tablet, the composition according to the present invention is mixed with excipients such as lactose, starch and crystalline cellulose, and a binder such as hydroxypropyl cellulose, and after granulation and drying using a solvent. Ordinary tablets can be produced by tableting with a lubricant such as stearic acid.

 更に本発明にかかるチュアブル剤は、ビフィズス菌、ビタミンB2、ビタミンB6及びビタミンCを含有するチュアブル剤である。本発明にかかるチュアブル剤を製造するには、ビタミンB2、ビタミンB6及びビタミンCにショ糖、マンニトール等の甘味を有する賦形剤とヒドロキシプロピルセルロース等の結合剤、更に必要に応じ矯味矯臭剤を混合し、溶媒を加えて造粒、乾燥後、ビフィズス菌、滑沢剤を添加、打錠して得ることができる。打錠圧は一般の錠剤を製造するよりも高くし、一般に崩壊剤を使用しない。チュアブル剤とは、口中において徐々に溶かすか又はかみ砕いて服用するものであり、日本薬局方製剤総則におけるトローチ剤と同様な製剤であるが、本発明にかかるチュアブル剤は、口腔粘膜又は咽頭粘膜局所に対する作用を期待するものではない。本発明にかかる組成物又はチュアブル剤を服用すると、消化管内においてビフィズス菌の増殖が促進され、排便促進作用、整腸作用がもたらされるため、本発明は、ビフィズス菌、ビタミンB2、ビタミンB6及びビタミンCを含有する排便促進剤又は整腸剤を提供するものである。 Furthermore, the chewable agent according to the present invention is a chewable agent containing bifidobacteria, vitamin B2, vitamin B6 and vitamin C. In order to produce the chewable preparation according to the present invention, vitamin B2, vitamin B6 and vitamin C are mixed with a sweetener such as sucrose and mannitol, a binder such as hydroxypropylcellulose, and a flavoring agent if necessary. After mixing, granulating and drying by adding a solvent, bifidobacteria and a lubricant are added and tableted. The tableting pressure is higher than that for producing ordinary tablets, and generally no disintegrant is used. A chewable agent is one that is gradually dissolved or chewed in the mouth and is a preparation similar to the troche in the Japanese Pharmacopoeia General Rules for Preparations. It does not expect local effects. When the composition or chewable agent according to the present invention is taken, the growth of bifidobacteria in the gastrointestinal tract is promoted, resulting in a defecation promoting action and an intestinal regulating action. A defecation promoter or intestinal regulating agent containing C is provided.

 以下に、実施例により本発明を説明する。 Hereinafter, the present invention will be described by way of examples.

 実施例1
 MCM培地1Lに表1で示す量のビタミンB2、ビタミンB6及びビタミンCを加えビフィズス菌(Bifidobacterium longum NT)約108cfu/Lを接種し、培地10mLを入れた試験管中で37℃24時間静置嫌気培養した。接種時と培養24時間後の生菌数を測定した結果を表2に示した。表2より明らかなようにビタミン無添加ではビフィズス菌の増殖はわずかであったが、ビタミン添加によりビフィズス菌は約100倍に増殖した。以上より、ビタミンB2、ビタミンB6及びビタミンCにビフィズス菌の増殖を促進する作用を有することが明らかである。
Example 1
Vitamin B2, vitamin B6, and vitamin C in the amounts shown in Table 1 are added to 1 L of MCM medium, inoculated with about 10 8 cfu / L of Bifidobacterium longum NT, and incubated at 37 ° C. for 24 hours in a test tube containing 10 mL of medium. Static anaerobic culture was performed. The results of measuring the number of viable bacteria at the time of inoculation and after 24 hours of culture are shown in Table 2. As is clear from Table 2, the growth of bifidobacteria was slight when no vitamin was added, but the bifidobacteria grew about 100 times by the addition of vitamin. From the above, it is clear that vitamin B2, vitamin B6, and vitamin C have an action of promoting the growth of bifidobacteria.

Figure 2004026840
Figure 2004026840

Figure 2004026840
Figure 2004026840

Claims (4)

 ビフィズス菌に、ビタミンB2、ビタミンB6及びビタミンCを配合することによるビフィズス菌の増殖促進方法。 A method for promoting the growth of bifidobacteria by adding vitamin B2, vitamin B6 and vitamin C to bifidobacteria.  ビタミンB2、ビタミンB6及びビタミンCを含有する、ビフィズス菌の増殖促進剤。 Bifidobacteria growth promoter containing vitamin B2, vitamin B6 and vitamin C.  ビフィズス菌、ビタミンB2、ビタミンB6及びビタミンCを含有する組成物。 Composition containing bifidobacteria, vitamin B2, vitamin B6 and vitamin C.  ビフィズス菌、ビタミンB2、ビタミンB6及びビタミンCを含有するチュアブル剤。
A chewable preparation containing bifidobacteria, vitamin B2, vitamin B6 and vitamin C.
JP2003284828A 2003-08-01 2003-08-01 Viable bacteria composition Expired - Lifetime JP4694777B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003284828A JP4694777B2 (en) 2003-08-01 2003-08-01 Viable bacteria composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003284828A JP4694777B2 (en) 2003-08-01 2003-08-01 Viable bacteria composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP36225499A Division JP3478773B2 (en) 1999-12-21 1999-12-21 Viable bacteria composition

Publications (2)

Publication Number Publication Date
JP2004026840A true JP2004026840A (en) 2004-01-29
JP4694777B2 JP4694777B2 (en) 2011-06-08

Family

ID=31185547

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003284828A Expired - Lifetime JP4694777B2 (en) 2003-08-01 2003-08-01 Viable bacteria composition

Country Status (1)

Country Link
JP (1) JP4694777B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112638421A (en) * 2018-08-29 2021-04-09 帝斯曼知识产权资产管理有限公司 Preparation for improving intestinal health

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59132884A (en) * 1983-01-20 1984-07-31 Dai Ichi Seiyaku Co Ltd Composition for promoting propagation of bifidobacterium
JPS6037953A (en) * 1983-08-11 1985-02-27 Herusu Eido:Kk Nutrient supplement food composed mainly of calcium
JPS6188859A (en) * 1984-10-05 1986-05-07 Fuji Yakuhin Kogyo Kk Food containing lactobacillus bifidus
JPS61231966A (en) * 1985-04-06 1986-10-16 Nikken Food Honsha Kk Food for multiplying useful bacterium in intestine
US4756913A (en) * 1985-09-30 1988-07-12 Khorkova Evgenia A Sour milk product
DE4132296C1 (en) * 1991-09-27 1992-12-17 Karl Heinz 8081 Schoengeising De Hoelzel Enzymic metabolic prod. prepn. for intestinal disorders etc. - obtd. from pathogenic lacto- and bifido- bacteria from the gut
JPH07277990A (en) * 1994-03-31 1995-10-24 Snow Brand Milk Prod Co Ltd Bifid bacteria multiplication-stimulating agent
JPH10175867A (en) * 1996-12-12 1998-06-30 Morinaga Milk Ind Co Ltd Bifidus bacteria multiplication accelerating composition and its use

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59132884A (en) * 1983-01-20 1984-07-31 Dai Ichi Seiyaku Co Ltd Composition for promoting propagation of bifidobacterium
JPS6037953A (en) * 1983-08-11 1985-02-27 Herusu Eido:Kk Nutrient supplement food composed mainly of calcium
JPS6188859A (en) * 1984-10-05 1986-05-07 Fuji Yakuhin Kogyo Kk Food containing lactobacillus bifidus
JPS61231966A (en) * 1985-04-06 1986-10-16 Nikken Food Honsha Kk Food for multiplying useful bacterium in intestine
US4756913A (en) * 1985-09-30 1988-07-12 Khorkova Evgenia A Sour milk product
DE4132296C1 (en) * 1991-09-27 1992-12-17 Karl Heinz 8081 Schoengeising De Hoelzel Enzymic metabolic prod. prepn. for intestinal disorders etc. - obtd. from pathogenic lacto- and bifido- bacteria from the gut
JPH07277990A (en) * 1994-03-31 1995-10-24 Snow Brand Milk Prod Co Ltd Bifid bacteria multiplication-stimulating agent
JPH10175867A (en) * 1996-12-12 1998-06-30 Morinaga Milk Ind Co Ltd Bifidus bacteria multiplication accelerating composition and its use

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
BIOSCIENCE MICROFLORA (1998), VOL.17, NO.1, P.49-53, JPN4007013180, ISSN: 0000852839 *
BIOSCIENCE MICROFLORA (1998), VOL.17, NO.1, P.49-53, JPN4007021306, ISSN: 0000888180 *
JAPANESE JOURNAL OF DAIRY AND FOOD SCIENCE (1987), VOL.36, NO.6, P.257-264, JPN6007012925, ISSN: 0000943351 *
MARK POCH ET.AL., GROWTH-ENHANCING SUPPLEMENTS FOR VARIOUS SPECIES OF THE GENUS BIFIDOBACTERIUM., J., JPN4007012960, ISSN: 0000852838 *
MARK POCH ET.AL., GROWTH-ENHANCING SUPPLEMENTS FOR VARIOUS SPECIES OF THE GENUS BIFIDOBACTERIUM., J., JPN4007021307, ISSN: 0000888181 *
R. Y. スタニエ, 微生物学(上)原書第5版, JPN4007021039, 10 July 1989 (1989-07-10), pages 20 - 32, ISSN: 0000888178 *
七字三郎著、「微生物工学の応用」、共立出版株式会社、昭和47年12月1日発行、第110ページ, JPN4007021038, ISSN: 0000888177 *
東京大学医科学研究所学友会編, 改訂第5版 細菌学実習提要, JPN4007021040, 31 March 1976 (1976-03-31), pages 99 - 101, ISSN: 0000888179 *
柳田友道著、「微生物科学 3.形態形成」、株式会社学会出版センター、1982年6月25日発行、第30-35ページ, JPN4007021037, ISSN: 0000888176 *
腸内細菌学雑誌、(1999 FEB), VOL.12, P.73-79, JPN6007012922, ISSN: 0000943350 *

Also Published As

Publication number Publication date
JP4694777B2 (en) 2011-06-08

Similar Documents

Publication Publication Date Title
EP1609852B1 (en) Bifidobacteria and preparations containing them
US6468525B1 (en) Probiotic formulation
Kolida et al. Prebiotic effects of inulin and oligofructose
AU2007300461B2 (en) Probiotic oral dosage forms
EP0555618B1 (en) Dietetic and/or pharmaceutical compositions containing lyophilized lactic bacteria
KR20170053733A (en) Prebiotic formulations and methods of use
CN106974262B (en) Application of intestinal probiotic bacillus in treating and preventing obesity and related diseases
JP2002522393A (en) Method for increasing the solubility of nutrient materials using symbiotic lactic acid producing bacteria
CN109419816B (en) Application of bacteroides cellulolyticus in preventing and/or treating heart diseases
AU2011314299B2 (en) Compositions and methods for augmenting kidney function
JP2018532380A (en) Enterobacteriaceae butyric acid intestini and uses thereof
JP3478773B2 (en) Viable bacteria composition
JP2021505609A (en) Use of BUTYRlBACTER INTERSTINI in the prevention and / or treatment of inflammation-related diseases
WO2018107365A1 (en) Anaerostipes caccae and applications thereof
CN110869035B (en) Application of African adequacy bacterium to preparation of composition for preventing and/or treating lipid metabolism related diseases
JP4694777B2 (en) Viable bacteria composition
EP4422652A1 (en) Probiotic composition for gut microbiome modulation
CN106974940B (en) Application of probiotics of scleritis in treating and preventing obesity and related diseases
KR102685867B1 (en) Pharmaceutical composition for preventing or treating the acquisition of drug-resistant infections comprising a combination of probiotics and prebiotics
CN106974939B (en) Application of probiotics of scleritis in treating and preventing obesity and related diseases
EP1719518A1 (en) Compositions comprising bacillus coagulans for increasing the solubility and bioavailability of nutritional minerals
JPH01121219A (en) Anti-clostridium agent containing living bacteria
CN115666276A (en) Fiber blend formulations and uses thereof
WO2024026339A2 (en) Probiotic blend supplement with micronutrients for infant and children&#39;s health

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20060808

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070515

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070702

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070705

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070821

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071211

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080123

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080417

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110224

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140304

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4694777

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140304

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140304

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140304

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term